Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 3 12Phase NA 8Phase 1/2 8Phase 4 6Phase 2/3 5Phase 1 3

Status

Completed 110Terminated 18Withdrawn 7Active not recruiting 5Unknown 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1

Conditions

Carcinoma, Hepatocellular 2Pancreatic Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Sorafenib × Clear all
NCT02716012 2025-03-10

OUTREACH

Mina Alpha Limited

Phase 1 Unknown
75 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02423239 2016-04-06

A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

e-Therapeutics PLC

Phase 1 Unknown
112 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT01932177 2013-08-30

EVESOR

Hospices Civils de Lyon

Phase 1 Unknown
60 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡